Accession Number:



Alleviating Autonomic Dysreflexia after Spinal Cord Injury

Descriptive Note:

[Technical Report, Final Report]

Corporate Author:

Drexel University

Personal Author(s):

Report Date:


Pagination or Media Count:



Spinal cord injury SCI is a devastating event sustained by our servicemembers and as many as 1.3 million Americans that results in the disruption of normal autonomic function, including cardiovascular control. Up to 70-90 of patients who have sustained a high SCI above thoracic level 6 of spinal cord suffer from the serious and life-threatening complication of autonomic dysreflexia. Autonomic dysreflexia manifests as sudden and extreme hypertension that is usually triggered by an annoying noxious or non-noxious stimulus below the level of injury, frequently initiated in the bladder or bowel. It is a key contributor to cardiovascular disease, the leading cause of morbidity and mortality for chronically injured individuals with SCI. However, the only current treatments available to treat autononic dysreflexia are palliative and involve pharmacological vasodilators that merely help to manage the symptoms of autonomic dysreflexia after an episode has already been initiated. Thus, developing treatments to help prevent the development of this syndrome or decrease its severity is highly important.

Subject Categories:

  • Medicine and Medical Research
  • Anatomy and Physiology

Distribution Statement:

[A, Approved For Public Release]